JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

Search

Codexis Inc

Chiusa

SettoreSettore sanitario

2.83 -6.6

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

2.8

Massimo

3.06

Metriche Chiave

By Trading Economics

Entrata

-10M

-21M

Vendite

-14M

7.5M

Margine di Profitto

-274.268

Dipendenti

188

EBITDA

-11M

-20M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+93.42% upside

Dividendi

By Dow Jones

Utili prossimi

7 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

17M

235M

Apertura precedente

9.43

Chiusura precedente

2.83

Notizie sul Sentiment di mercato

By Acuity

65%

35%

339 / 375 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Codexis Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

29 lug 2025, 23:57 UTC

Acquisizioni, Fusioni, Takeovers

EQT: To Spend Y407.82B for Tender Offer

29 lug 2025, 23:56 UTC

Acquisizioni, Fusioni, Takeovers

EQT: Tender Offer Price Is Y5,700 a Share

29 lug 2025, 23:54 UTC

Acquisizioni, Fusioni, Takeovers

EQT To Start Tender Offer for Fujitec

29 lug 2025, 23:50 UTC

Discorsi di Mercato

Nikkei May Fall Amid Uncertainty Over Earnings, Domestic Politics -- Market Talk

29 lug 2025, 23:36 UTC

Discorsi di Mercato

Gold Steady Ahead of FOMC Decision -- Market Talk

29 lug 2025, 22:57 UTC

Discorsi di Mercato

Perseus May Step Up Capital Management at FY 2025 Result -- Market Talk

29 lug 2025, 22:50 UTC

Discorsi di Mercato

Mondelez Warns of Price Increases in North America -- Market Talk

29 lug 2025, 22:44 UTC

Acquisizioni, Fusioni, Takeovers

St Barbara: Potential Divestment of Nova Scotia Ops to be Weighed in 1Q FY26

29 lug 2025, 22:41 UTC

Acquisizioni, Fusioni, Takeovers

St Barbara FY25 All-in Sustaining Cost A$4,582/Oz

29 lug 2025, 22:41 UTC

Acquisizioni, Fusioni, Takeovers

St Barbara 4Q All-in Sustaining Cost A$4,613/Oz

29 lug 2025, 22:35 UTC

Utili

IGO Maintains Nova Life of Mine Production Guidance

29 lug 2025, 22:35 UTC

Utili

IGO Expects FY 2026 Greenbushes Output of 1.50 Million-1.65 Million Tons

29 lug 2025, 22:35 UTC

Utili

IGO Expects FY 2026 Greenbushes Cash Costs of A$310-A$360/Ton

29 lug 2025, 22:34 UTC

Utili

IGO Expects Train 1 of Kwinana Refinery to Be Fully Impaired

29 lug 2025, 22:34 UTC

Utili

IGO Expects to Impair Kwinana Refinery Assets by A$70 Million-A$90 Million

29 lug 2025, 22:34 UTC

Discorsi di Mercato
Utili

Mondelez Snack Demand Holding Up Better in Europe Than U.S. -- Market Talk

29 lug 2025, 22:33 UTC

Utili

IGO Had A$279.7 Million of Cash at End-June

29 lug 2025, 22:33 UTC

Utili

IGO 4Q Underlying Free Cash A$2.4 Million

29 lug 2025, 22:33 UTC

Utili

IGO FY Sales Revenue A$512.5 Million

29 lug 2025, 22:33 UTC

Utili

IGO 4Q Sales Revenue A$126.9 Million, Up 15% on 3Q

29 lug 2025, 22:32 UTC

Utili

IGO FY Nickel Production 17,173 Tons

29 lug 2025, 22:32 UTC

Utili

IGO 4Q Nickel Production 5,107 Tons, Up 22% on 3Q

29 lug 2025, 22:32 UTC

Utili

IGO 4Q Lithium Hydroxide Production 2,126 Tons, Up 36% on 3Q

29 lug 2025, 22:31 UTC

Discorsi di Mercato
Utili

Global Equities Roundup: Market Talk

29 lug 2025, 22:31 UTC

Discorsi di Mercato
Utili

Mondelez Sees Consumers Trading Down, Buying in Bulk -- Market Talk

29 lug 2025, 22:31 UTC

Utili

IGO 4Q Spodumene Cash Cost A$366/Ton, Up 7% on 3Q

29 lug 2025, 22:31 UTC

Utili

IGO FY Spodumene Production 1.48 Million Tons

29 lug 2025, 22:30 UTC

Utili

IGO 4Q Spodumene Production 340,000 Tons, Flat on 3Q

29 lug 2025, 22:30 UTC

Utili

IGO 4Q Underlying Ebitda A$62 Million

29 lug 2025, 22:22 UTC

Utili

Starbucks Abandons Mobile Order, Pickup-Only Stores -- WSJ

Confronto tra pari

Modifica del prezzo

Codexis Inc Previsione

Obiettivo di Prezzo

By TipRanks

93.42% in crescita

Previsioni per 12 mesi

Media 5.88 USD  93.42%

Alto 11 USD

Basso 3 USD

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Codexis Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

5 ratings

4

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

2.25 / 2.53Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

339 / 375 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.